Fosmidomycin/Piperaquine

N/A

Report date: 2025/03/26 20:01:25
NME

Base Information

Drug NameFosmidomycin/Piperaquine
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionOxidoreductases inhibitorsProtein biosynthesis inhibitors
TargetsOxidoreductases
Therapy Area/IndicationsMalaria, Falciparum
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes FosmidomycinPiperaquine
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJomaa Pharma Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJomaa Pharma Gmbh
Active IndicationsN/A
Inactive IndicationsMalaria, Falciparum

Other Information

ATC CodeN/A
Related LinksN/A